New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
09:16 EDTDISH, GTAT, NQ, BDSI, ARNA, ENDP, CASI, SPPIOn The Fly: Pre-market Movers
HIGHER: DISH (DISH), up 2.4% following positive mention in this weekend's Barron's, contending the shares could climb 20%... BioDelivery Sciences (BDSI), up 15% after announcing results from its Endo buprenorphine trial with an Endo (ENDP) division... CASI Pharmaceuticals (CASI), up 3.7% after confirming that it received FDA orphan drug designation for a drug... Spectrum (SPPI), up 3% after being granted accelerated approval for Beleodaq from FDA. LOWER: GT Advanced (GTAT), down 10% after downgraded at UBS and Cannaccord... NQ Mobile (NQ), down 3.5% after Muddy Waters says the company has likely already decided to fire PwC... Arena Pharmaceuticals (ARNA), down 3% after Chairman, President and CEO Jack Lief sold 223,525 shares of the company's common stock pursuant to a Rule 10b5-1 trading plan on July 1, according to a regulatory filing from late Thursday.
News For DISH;GTAT;NQ;BDSI;ARNA;ENDP;CASI;SPPI From The Last 14 Days
Check below for free stories on DISH;GTAT;NQ;BDSI;ARNA;ENDP;CASI;SPPI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 29, 2014
08:19 EDTARNAArena Pharma' and Eisai announce nomination of BELVIQ by Gallen Foundation
Eisai and Arena Pharmaceuticals (ARNA) announced that BELVIQ, or lorcaserin HCl, has been nominated by the Galien Foundation and Awards Committee for the 2014 Prix Galien USA Award in the Best Pharmaceutical Agent category. BELVIQ was previously nominated for this award in 2013.
July 28, 2014
16:00 EDTNQOptions Update; July 28, 2014
Subscribe for More Information
10:22 EDTGTATMIT Technology Review discusses new sapphire production at GT
Subscribe for More Information
July 25, 2014
08:38 EDTNQNQ Mobile August weekly volatility at 134 into Q3
Subscribe for More Information
July 23, 2014
10:02 EDTENDPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:41 EDTNQNQ Mobile and A Wireless partner for device security solution
NQ Mobile (NQ) and A Wireless, one of the largest Verizon (VZ) Wireless Premium Retailers, announced the availability of a comprehensive, bundled security solution that ensures the safety of subscribers' devices and the valuable data they hold. The solution is available at over 200 A Wireless stores across the US. The new package combines physical device insurance with NQ Mobile's security protection for both iOS and Android.
08:10 EDTENDPDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTENDPEndo initiated with a Buy at Deutsche Bank
Subscribe for More Information
05:55 EDTNQStocks with implied volatility movement; NQ HPQ
Stocks with implied volatility movement; NQ Mobile (NQ) 169, Hewlett-Packard (HPQ) 28 according to iVolatility.
July 21, 2014
08:11 EDTARNAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
07:04 EDTCASICASI Pharmaceuticals' receives approval from CFDA to conduct clinical trial
CASI Pharmaceuticals announced that China's Food and Drug Administration, or CFDA has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer patients in China for its proprietary drug candidate, ENMD-2076.
July 18, 2014
09:48 EDTNQActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL NQ GOOG GOOGL TSLA KGC TWTR AMZN ELNK AMGN FB
09:24 EDTNQOn The Fly: Pre-market Movers
Subscribe for More Information
07:10 EDTNQNQ Mobile engages Marcum Berstein & Pinchuk as independent auditor
Subscribe for More Information
July 16, 2014
10:01 EDTDISHNTELOS expansion of DISH program an incremental positive, says Wells Fargo
Wells Fargo views the expansion of NTELOS' (NTLS) fixed wireless broadband program with DISH (DISH) as an incremental positive for NTELOS and the firm believes the company's 2.5GHZ spectrum is an "important hidden asset." Wells thinks NTELOS will keep seeking "out of the box" partnerships in its service areas and keeps its Outperform rating on the stock.
09:58 EDTDISHNTELOS, DISH expand Internet service pact to Virginia
Subscribe for More Information
09:37 EDTARNAActive equity options trading on open
Subscribe for More Information
07:43 EDTDISHSenate Commerce, Science & Transportation Committee holds a hearing
Subscribe for More Information
July 15, 2014
16:34 EDTARNAArena Pharmaceuticals granted patent for Cannabinoid Receptor Modulators
Arena Pharmaceuticals announced that it was granted U.S. Patent No. 8,778,950, entitled "Cannabinoid Receptor Modulators," by the U.S. Patent and Trademark Office for APD371, an agonist of the cannabinoid receptor 2. Arena is exploring several potential indications for APD371, including chronic pain, and is currently conducting a Phase 1 single-ascending dose trial.
10:40 EDTARNAArena Pharmaceuticals receives USPTO patent for cannabinoid receptor modulators
Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use